Oramed Pharmaceuticals (ORMP) Capital Expenditures (2011 - 2026)
Oramed Pharmaceuticals (ORMP) posted Capital Expenditures of $5000.0 for Q1 2026, up 150.0% on a QoQ basis from $2000.0 in Q4 2025, and up 66.67% year-over-year from $3000.0 in Q1 2025.
Oramed Pharmaceuticals (ORMP) Capital Expenditures (2011 - 2026) Analysis & Trends
Oramed Pharmaceuticals' Capital Expenditures history runs 15 years deep, the most recent figure standing at $5000.0 for Q1 2026.
- Quarterly Capital Expenditures rose 66.67% year-over-year to $5000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11000.0 (down 42.11% YoY) and the FY2025 annual result came in at $9000.0, down 50.0% from the prior year.
- Capital Expenditures was $5000.0 for Q1 2026 at Oramed Pharmaceuticals, up from $2000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $308000.0 in Q4 2022 and bottomed at $2000.0 in Q1 2024.
- A 5-year average of $52133.3 and a median of $11000.0 in 2024 frame the typical range for Capital Expenditures.
- Peak annual rise in Capital Expenditures reached 323.4% in 2023, while the deepest fall reached 99.03% in 2023.
- Oramed Pharmaceuticals' Capital Expenditures stood at $308000.0 in 2022, then plunged by 99.03% to $3000.0 in 2023, then jumped by 266.67% to $11000.0 in 2024, then plunged by 81.82% to $2000.0 in 2025, then surged by 150.0% to $5000.0 in 2026.
- Business Quant data shows ORMP's Capital Expenditures at $5000.0 in Q1 2026, $2000.0 in Q4 2025, and $4000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | Oramed Pharmaceuticals | 170.25 Mn | 170.25 Mn | - | 5,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5,000.00 |
| Mar 31, 2026 | 5,000.00 |
| Dec 31, 2025 | 2,000.00 |
| Dec 31, 2025 | 2,000.00 |
| Jun 30, 2025 | 4,000.00 |
| Jun 30, 2025 | 4,000.00 |
| Mar 31, 2025 | 3,000.00 |
| Mar 31, 2025 | 3,000.00 |
| Dec 31, 2024 | 11,000.00 |
| Dec 31, 2024 | 11,000.00 |
| Sep 30, 2024 | 5,000.00 |
| Sep 30, 2024 | 5,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Dec 31, 2023 | 3,000.00 |
| Dec 31, 2023 | 3,000.00 |
| Sep 30, 2023 | 32,000.00 |
| Sep 30, 2023 | 32,000.00 |
| Jun 30, 2023 | 20,000.00 |
| Jun 30, 2023 | 20,000.00 |